KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Net Income: 2009-2025

Historic Net Income for Idexx Laboratories (IDXX) over the last 17 years, with Sep 2025 value amounting to $274.6 million.

  • Idexx Laboratories' Net Income rose 17.94% to $274.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 billion, marking a year-over-year increase of 18.61%. This contributed to the annual value of $887.9 million for FY2024, which is 5.07% up from last year.
  • Per Idexx Laboratories' latest filing, its Net Income stood at $274.6 million for Q3 2025, which was down 6.59% from $294.0 million recorded in Q2 2025.
  • Idexx Laboratories' 5-year Net Income high stood at $294.0 million for Q2 2025, and its period low was $132.0 million during Q2 2022.
  • Over the past 3 years, Idexx Laboratories' median Net Income value was $224.2 million (recorded in 2023), while the average stood at $231.3 million.
  • In the last 5 years, Idexx Laboratories' Net Income soared by 82.64% in 2021 and then slumped by 34.86% in 2022.
  • Idexx Laboratories' Net Income (Quarterly) stood at $162.8 million in 2021, then grew by 5.80% to $172.2 million in 2022, then grew by 12.96% to $194.5 million in 2023, then rose by 11.12% to $216.1 million in 2024, then climbed by 17.94% to $274.6 million in 2025.
  • Its last three reported values are $274.6 million in Q3 2025, $294.0 million for Q2 2025, and $242.7 million during Q1 2025.